(Q35622046)

9 August 2017

1 reference

title

Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit? (English)

1 reference

9 August 2017

main subject

arterial hypertension

1 reference

Martine Clozel

1

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

35

1 reference

9 August 2017

issue

8

1 reference

9 August 2017

page(s)

605-613

1 reference

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

The role of endothelin in experimental cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Measurement of endothelin: clinical and research use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Augmentation of endothelial function by endothelin antagonism in human saphenous vein conduits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Endothelin receptor blockade improves endothelial function in human internal mammary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Angiogenesis and pulmonary hypertension: a unique process in a unique disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Mixed endothelin ET(A) and ET(B) antagonist bosentan inhibits oleic acid-induced lung plasma extravasation in mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Role for endogenous endothelin in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Aldosterone-induced cardiac damage: focus on blood pressure independent effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Acute pulmonary hypertension after cardiopulmonary bypass in pig: the role of endogenous endothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Endothelin-B receptors mediate intimal hyperplasia in an organ culture of human saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Endothelin adrenocortical secretagogue effect is mediated by the B receptor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

The endothelin-aldosterone axis and cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

Selective Endothelin-A Versus Combined Endothelin-A/Endothelin-B Receptor Blockade in Rat Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017477

10.1080/07853890310017477

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference